MULTIFOCAL MICRONODULAR PNEUMOCYTE HYPERPLASIA

MULTIFOCAL MICRONODULAR PNEUMOCYTE HYPERPLASIA was reported 34 times

MULTIFOCAL MICRONODULAR PNEUMOCYTE HYPERPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RILUZOLE 1 0.0004
1 ARSENIC TRIOXIDE 1 0.0004
2 DOCETAXEL ANHYDROUS 24 0.0004
3 DOCETAXEL 24 0.0004
4 TRASTUZUMAB 20 0.0003
5 GEMTUZUMAB OZOGAMICIN 1 0.0003
6 MYCOPHENOLATE MOFETIL 22 0.0002
7 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 22 0.0002
8 ANTI-THYMOCYTE GLOBULIN (RABBIT) 1 0.0001
9 SIROLIMUS 1 0.0001
10 CYCLOPHOSPHAMIDE FOR INJECTION 13 0.0001
11 CYCLOPHOSPHAMIDE 13 0.0001
12 TOLVAPTAN 1 0.0001
13 KETOCONAZOLE FOAM 1 0.0001
14 KETOCONAZOLE CREAM, 2% 1 0.0001
15 KETOCONAZOLE 1 0.0001
16 NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE 1 0.0000
17 PREDNISONE 24 0.0000
18 MYCOPHENILIC ACID 1 0.0000
19 MYCOPHENOLIC ACID 1 0.0000
20 LIDICAINE 1 0.0000
21 EVEROLIMUS 1 0.0000
22 LIDOCAINE, MENTHOL 1 0.0000
23 MEPOLIZUMAB 1 0.0000
24 LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 1 0.0000
25 LIDOCAINE 4% 1 0.0000
26 DOCUSATE SODIUM 1 0.0000
27 AZITHROMYCIN DIHYDRATE 1 0.0000
28 FINASTERIDE 1 0.0000
29 LIDOCAINE HYDROCHLORIDE 1 0.0000
30 FLUCONAZOLE 1 0.0000
31 POLYETHYLENE GLYCOL 3350 1 0.0000
32 BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE 1 0.0000
33 ACYCLOVIR 1 0.0000
34 SERTRALINE HYDROCHLORIDE 1 0.0000
35 TACROLIMUS OINTMENT 0.1% 1 0.0000
36 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
37 ATENOLOL 1 0.0000
38 LEVETIRACETAM 1 0.0000
39 TIOTROPIUM BROMIDE 1 0.0000
40 ESCITALOPRAM 1 0.0000
41 TACROLIMUS 1 0.0000
42 ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE 1 0.0000
43 ALBUTEROL SULFATE 1 0.0000
44 LEVOTHYROXINE SODIUM 1 0.0000
45 OMEPRAZOLE MAGNESIUM 1 0.0000
46 ACETAMINOPHEN 1 0.0000